etidronate has been researched along with Aging in 16 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "If patients with osteoporosis are being diagnosed and effective treatments used with increasing frequency in the population, rates of hip and wrist fractures will remain stable or possibly decrease." | 1.33 | Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? ( Adachi, JD; Hawker, G; Jaakkimainen, L; Jaglal, SB; Kreder, H; Mamdani, M; Weller, I, 2005) |
| " These findings indicated that the long-term administration of PGE2 alone cannot maintain or continue to add bone mass in ovx rats but that co-treatment of a PGE2 with an anti-resorptive or activation agent can resist the influence of the mechanostat induced bone loss as well as continue to add bone." | 1.29 | Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. ( Chen, YY; Ijiri, K; Jee, WS; Ke, HZ; Ma, Y, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 9 (56.25) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verhaar, HJ | 1 |
| Fukunaga, M | 1 |
| Jaglal, SB | 1 |
| Weller, I | 1 |
| Mamdani, M | 1 |
| Hawker, G | 1 |
| Kreder, H | 1 |
| Jaakkimainen, L | 1 |
| Adachi, JD | 1 |
| Ito, M | 1 |
| Nakayama, K | 1 |
| Konaka, A | 1 |
| Sakata, K | 1 |
| Ikeda, K | 1 |
| Maruyama, T | 1 |
| Fogelman, I | 1 |
| Bessent, RG | 1 |
| Gordon, D | 1 |
| Qi, H | 1 |
| Li, M | 1 |
| Wronski, TJ | 2 |
| Jee, WS | 5 |
| Lin, BY | 2 |
| Ma, YF | 3 |
| Ke, HZ | 5 |
| Steiniche, T | 1 |
| Li, QN | 1 |
| Xie, H | 1 |
| Huang, LF | 1 |
| Liang, NC | 1 |
| Ma, Y | 1 |
| Chen, YY | 2 |
| Ijiri, K | 1 |
| Lin, CH | 1 |
| Li, XJ | 1 |
| Mosekilde, L | 2 |
| Thomsen, JS | 2 |
| McOsker, JE | 1 |
| Beauchesne, MF | 1 |
| Miller, PF | 1 |
| Trémollières, F | 1 |
| Iwaniec, UT | 1 |
| Mitova-Caneva, NG | 1 |
| Tang, LY | 1 |
| Kimmel, DB | 1 |
4 reviews available for etidronate and Aging
| Article | Year |
|---|---|
[Bone mass measurement and evaluation of therapeutical response].
Topics: Absorptiometry, Photon; Aging; Alendronate; Biomarkers; Bone Density; Calcium; Estrogen Replacement | 2004 |
Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
Topics: Adult; Aged; Aging; Benzothiadiazines; Bone and Bones; Calcium; Diuretics; Estrogens; Etidronic Acid | 1995 |
Etidronate and alendronate in the treatment of postmenopausal osteoporosis.
Topics: Aging; Alendronate; Bone Density; Clinical Trials as Topic; Data Collection; Etidronic Acid; Female; | 1999 |
[Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Topics: Aging; Alendronate; Diphosphonates; Estrogen Replacement Therapy; Etidronic Acid; Female; Humans; Mi | 2001 |
12 other studies available for etidronate and Aging
| Article | Year |
|---|---|
[Treatment of osteoporosis in the elderly: what is the evidence?].
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alendronate; Bone Density; Bone Density Conservation Ag | 2008 |
Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?
Topics: Aged; Aging; Bone Density; Drug Prescriptions; Etidronic Acid; Female; Fractures, Bone; Hip Fracture | 2005 |
Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats.
Topics: Aging; Animals; Bone Density; Etidronic Acid; Female; Heptanoates; Ovariectomy; Prostaglandins E; Ra | 2006 |
A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease.
Topics: Adult; Aged; Aging; Bone and Bones; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bon | 1981 |
A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
Topics: Aging; Animals; Biomarkers; Bone Development; Bone Diseases, Metabolic; Bone Remodeling; Calcitonin; | 1995 |
Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
Topics: Aging; Analysis of Variance; Animals; Body Weight; Bone Development; Bone Resorption; Calcium Channe | 1995 |
Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
Topics: Aging; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Interactions; Etidronic Acid; Femal | 1995 |
Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
Topics: Aging; Animals; Body Weight; Bone Development; Bone Diseases, Metabolic; Dinoprostone; Drug Therapy, | 1995 |
Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
Topics: Age Factors; Aging; Animals; Bone and Bones; Bone Density; Calcium Channel Blockers; Dinoprostone; D | 1997 |
No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.
Topics: Aging; Animals; Biomechanical Phenomena; Bone and Bones; Bone Diseases, Metabolic; Calcium Channel B | 1997 |
Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Topics: Aging; Animals; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Ca | 2002 |
Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
Topics: Aging; Animals; Body Weight; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Resorption | 1992 |